Germline Mutations in Predisposition Genes in Pediatric Cancer

Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · see citing works

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology

Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594 · see citing works

A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1

Miki, Y., Swensen, J. J., Shattuck-Eidens, D. M., Futreal, P. A., Harshman, K., Tavtigian, S. V., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,069 · see citing works

Mutational heterogeneity in cancer and the search for new cancer-associated genes

Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461 · see citing works

Identification of the breast cancer susceptibility gene BRCA2

Wooster, R., Bignell, G. R., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S. G., Gumbs, C. E., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645 · see citing works

A census of human cancer genes

Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1299 · Cited by 3,184 · see citing works

Enhancements and modifications of primer design program Primer3

Kõressaar, T., & Remm, M. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm091 · Cited by 2,618 · see citing works

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing

Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., McGuire, A. L., Nussbaum, R. L., O’Daniel, J. M., Ormond, K. E., et al. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.73 · Cited by 2,544 · see citing works

Principles and Practice of Pediatric Oncology

(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-8-636_3 · Cited by 2,034 · see citing works

The genetic basis of early T-cell precursor acute lymphoblastic leukaemia

Zhang, J., Ding, L., Holmfeldt, L., Wu, G., Heatley, S. L., Payne-Turner, D., Easton, J., Chen, X., Wang, J., Rusch, M., et al. (2012) · Nature · doi:10.1038/nature10725 · Cited by 1,596 · see citing works

Biallelic Inactivation of <i>BRCA2</i> in Fanconi Anemia

Howlett, N. G., Taniguchi, T., Olson, S., Cox, B., Waisfisz, Q., de Die-Smulders, C., Persky, N., Grompe, M., Joenje, H., Pals, G., et al. (2002) · Science · doi:10.1126/science.1073834 · Cited by 1,149 · see citing works

The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma

Wu, G., Li, Y., Qu, C., Chen, X. '., Edmonson, M. N., Ma, X., Nagahawatte, P., Hedlund, E., Rusch, M., Huether, R., et al. (2014) · Nature Genetics · doi:10.1038/ng.2938 · Cited by 1,101 · see citing works

Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE

Mavaddat, N., Peock, S., Frost, D., Ellis, S., Platte, R., Fineberg, E., Evans, D. G., Izatt, L., Eeles, R. A., Adlard, J., et al. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt095 · Cited by 951 · see citing works

Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update

Pui, C., Carroll, W. L., Meshinchi, S., & Arceci, R. J. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.7405 · Cited by 840 · see citing works

dbNSFP: A lightweight database of human nonsynonymous SNPs and their functional predictions

Liu, X., Jian, X., & Boerwinkle, E. (2011) · Human Mutation · doi:10.1002/humu.21517 · Cited by 816 · see citing works

The genomic landscape of hypodiploid acute lymphoblastic leukemia

Holmfeldt, L., Wei, L., Díaz-Flores, E., Walsh, M. F., Zhang, J., Ding, L., Payne-Turner, D., Churchman, M. L., Andersson, A., Chen, S.-C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2532 · Cited by 722 · see citing works

Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer

Reid, S., Schindler, D., Hanenberg, H., Barker, K., Hanks, S., Kalb, R., Neveling, K., Kelly, P., Seal, S., Freund, M., et al. (2007) · Nature Genetics · doi:10.1038/ng1947 · Cited by 642 · see citing works

Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR

Bell, D. W., Gore, I., Okimoto, R. A., Godin-Heymann, N., Sordella, R., Mulloy, R., Sharma, S. V., Brannigan, B. W., Mohapatra, G., Settleman, J., et al. (2005) · Nature Genetics · doi:10.1038/ng1671 · Cited by 529 · see citing works

A novel retinoblastoma therapy from genomic and epigenetic analyses

Zhang, J., Benavente, C. A., McEvoy, J. D., Flores‐Otero, J., Ding, L., Chen, X. '., Ulyanov, A. V., Wu, G., Wilson, M. W., Wang, J., et al. (2012) · Nature · doi:10.1038/nature10733 · Cited by 515 · see citing works

CREST maps somatic structural variation in cancer genomes with base-pair resolution

Wang, J., Mullighan, C. G., Easton, J. B., Roberts, S., Heatley, S. L., Ma, J., Rusch, M., Chen, K., Harris, C. C., Ding, L., et al. (2011) · Nature Methods · doi:10.1038/nmeth.1628 · Cited by 485 · see citing works

Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy

Zhang, M. Y., Churpek, J. E., Keel, S., Walsh, T., Lee, M. K., Loeb, K. R., Gülsüner, S., Pritchard, C. C., Sánchez-Bonilla, M., Delrow, J. J., et al. (2015) · Nature Genetics · doi:10.1038/ng.3177 · Cited by 368 · see citing works

Next-generation sequencing for cancer diagnostics: a practical perspective.

Meldrum, C. J., Doyle, M., & Tothill, R. W. (2011) · Europe PMC (PubMed Central) · Cited by 356 · see citing works

A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia

Shah, S., Schrader, K. A., Waanders, E., Timms, A. E., Vijai, J., Miething, C., Wechsler, J., Yang, J. J. J., Hayes, J. E., Klein, R. J., et al. (2013) · Nature Genetics · doi:10.1038/ng.2754 · Cited by 328 · see citing works

TSGene: a web resource for tumor suppressor genes

Zhao, M., Sun, J., & Zhao, Z. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks937 · Cited by 325 · see citing works

Concise Handbook of Familial Cancer Susceptibility Syndromes - Second Edition

Lindor, N. M., McMaster, M. L., LINDOR, C. J., & Greene, M. H. (2008) · JNCI Monographs · doi:10.1093/jncimonographs/lgn001 · Cited by 309 · see citing works

Integrated analysis of germline and somatic variants in ovarian cancer

Kanchi, K., Johnson, K. J., Lu, C., McLellan, M. D., Leiserson, M. D. M., Wendl, M. C., Zhang, Q., Koboldt, D. C., Xie, M., Kandoth, C., et al. (2014) · Nature Communications · doi:10.1038/ncomms4156 · Cited by 294 · see citing works

The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly

Varga, E. A., Pastore, M., Prior, T. W., Herman, G. E., & McBride, K. L. (2009) · Genetics in Medicine · doi:10.1097/gim.0b013e31818fd762 · Cited by 293 · see citing works

An Inv(16)(p13.3q24.3)-Encoded CBFA2T3-GLIS2 Fusion Protein Defines an Aggressive Subtype of Pediatric Acute Megakaryoblastic Leukemia

Gruber, T. A., Gedman, A. L., Zhang, J., Koss, C., Marada, S., Ta, H. Q., Chen, S.-C., Su, X., Ogden, S. K., Dang, J., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.10.007 · Cited by 283 · see citing works

Biallelic Mutations in BRCA1 Cause a New Fanconi Anemia Subtype

Sawyer, S. L., Tian, L., Kähkönen, M., Schwartzentruber, J., Kircher, M., Majewski, J., Dyment, D. A., Innes, A. M., Boycott, K. M., Moreau, L. A., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-1156 · Cited by 283 · see citing works

The "Duty to Warn" a Patient's Family Members About Hereditary Disease Risks

Offit, K. (2004) · JAMA · doi:10.1001/jama.292.12.1469 · Cited by 270 · see citing works

Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study.

Armes, J. E., Trute, L., White, D., Southey, M. C., Hammet, F., Tesoriero, A. A., Hutchins, A., Dite, G. S., McCredie, M. R. E., Giles, G. G., et al. (1999) · PubMed · Cited by 236 · see citing works

Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families

Bougeard, G., Sesboüé, R., Baert-Desurmont, S., Vasseur, S., Martin, C., Tinat, J., Brugières, L., Chompret, A., Paillerets, B. B.-D., Stoppa-Lyonnet, D., et al. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2008.057570 · Cited by 230 · see citing works

Secondary Variants in Individuals Undergoing Exome Sequencing: Screening of 572 Individuals Identifies High-Penetrance Mutations in Cancer-Susceptibility Genes

Johnston, J. J., Rubinstein, W. S., Facio, F. M., Ng, D., Singh, L. N., Teer, J. K., Mullikin, J. C., & Biesecker, L. G. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.05.021 · Cited by 207 · see citing works

Bambino: a variant detector and alignment viewer for next-generation sequencing data in the SAM/BAM format

Edmonson, M. N., Zhang, J., Yan, C., Finney, R. P., Meerzaman, D. M., & Buetow, K. H. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr032 · Cited by 135 · see citing works

Loss of heterozygosity analysis at the BRCA loci in tumor samples from patients with familial breast cancer

Osório, A., de la Hoya, M., Rodríguez‐López, R., Martínez‐Ramírez, Á., Cazorla, A., Granizo, J. J., Esteller, M., Rivas, C., Caldés, T., & Benitez, J. J. (2002) · International Journal of Cancer · doi:10.1002/ijc.10337 · Cited by 125 · see citing works

Hereditary cancer risk assessment in a pediatric oncology follow‐up clinic

Knapke, S. C., Nagarajan, R., Correll, J., Kent, D. A., & Burns, K. C. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23283 · Cited by 105 · see citing works

CONSERTING: integrating copy-number analysis with structural-variation detection

Chen, X. '., Gupta, P., Wang, J., Nakitandwe, J., Roberts, K. G., Dalton, J., Parker, M. D., PATEL, S. N., Holmfeldt, L., Payne, D., et al. (2015) · Nature Methods · doi:10.1038/nmeth.3394 · Cited by 80 · see citing works

High Prevalence of BRCA1 and BRCA2 Germline Mutations with Loss of Heterozygosity in a Series of Resected Pancreatic Adenocarcinoma and Other Neoplastic Lesions

Lucas, A. L., Shakya, R., Lipsyc, M. D., Mitchel, E. B., Kumar, S., Hwang, C., Deng, L., DeVoe, C., Chabot, J. A., Szabolcs, M. J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3020 · Cited by 69 · see citing works

Methylation not a frequent “second hit” in tumors with germline BRCA mutations

Dworkin, A. M., Spearman, A. D., Tseng, S. Y., Sweet, K. M., & Toland, A. E. (2009) · Familial Cancer · doi:10.1007/s10689-009-9240-1 · Cited by 61 · see citing works

Comparison of p53 and Epidermal Growth Factor Receptor Gene Status Between Primary Tumors and Lymph Node Metastases in Non-Small Cell Lung Cancers

Chang, Y., Wu, C., Shih, J., & Lee, Y.-C. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-1295-6 · Cited by 56 · see citing works

Is There a Predisposition Gene for Ewing's Sarcoma?

Randall, R. L., Lessnick, S. L., Jones, K. B., Gouw, L. G., Cummings, J. E., Cannon‐Albright, L., & Schiffman, J. D. (2010) · Journal of Oncology · doi:10.1155/2010/397632 · Cited by 48 · see citing works

Loss of heterozygosity in normal breast epithelial tissue and benign breast lesions in BRCA1/2 carriers with breast cancer

Cavalli, L. R., Singh, B., Isaacs, C. J., Dickson, R. B., & Haddad, B. R. (2004) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(03)00282-6 · Cited by 45 · see citing works

Higher occurrence of childhood cancer in families with germline mutations in BRCA2, MMR and CDKN2A genes

Magnusson, S., Borg, Å., Kristoffersson, U., Nilbert, M. C., Wiebe, T., & Olsson, H. L. (2008) · Familial Cancer · doi:10.1007/s10689-008-9195-7 · Cited by 43 · see citing works

Loss of Heterozygosity at the BRCA2 Locus Detected by Multiplex Ligation-Dependent Probe Amplification is Common in Prostate Cancers from Men with a Germline BRCA2 Mutation

Willems, A. J., Dawson, S., Samaratunga, H., Luca, A. D., Antill, Y. C., Hopper, J. L., Thorne, H., & and kConFab Investigators (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5237 · Cited by 41 · see citing works

The “duty to warn” a patient’s family members about hereditary disease risks

Offit, K., Groeger, E., Turner, S., Wadsworth, E., & Weiser, M. (2005) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2004.12.097 · Cited by 40 · see citing works

Ewing sarcoma‐family tumors that arise after treatment of primary childhood cancer

Spunt, S. L., Galindo, C. R., Fuller, C. E., Harper, J. A., Krasin, M. J., Billups, C. A., & Khoury, J. D. (2006) · Cancer · doi:10.1002/cncr.21962 · Cited by 40 · see citing works

Childhood cancer in families with and without BRCA1 or BRCA2 mutations ascertained at a high-risk breast cancer clinic

Brooks, G. A., Stopfer, J. E., Erlichman, J., Davidson, R., Nathanson, K. L., & Domchek, S. M. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.9.3167 · Cited by 39 · see citing works

Ethical and Legal Implications of Cancer Genetic Testing: Do Physicians Have a Duty to Warn Patients' Relatives About Possible Genetic Risks?

Storm, C. D., Agarwal, R., & Offit, K. (2008) · Journal of Oncology Practice · doi:10.1200/jop.0858504 · Cited by 22 · see citing works

Risks to Relatives in Genomic Research: A Duty to Warn?

Bombard, Y., Offit, K., & Robson, M. E. (2012) · The American Journal of Bioethics · doi:10.1080/15265161.2012.699157 · Cited by 20 · see citing works

Frequent somatic loss of BRCA1 in breast tumours from BRCA2 germ-line mutation carriers and vice versa

Staff, S. M., Isola, J. J., Jóhannsson, Ó. Þ., Borg, Å., & Tanner, M. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2062 · Cited by 14 · see citing works

Ewing’s Sarcoma as Second Malignant Neoplasm after Retinoblastoma: A Case Report

Mittal, R., Alawadi, S., Sahar, O., & Behbehani, A. M. (2007) · Medical Principles and Practice · doi:10.1159/000109597 · Cited by 14 · see citing works

Intact T-cell regenerative capacity in childhood acute lymphoblastic leukemia after remission induction therapy

Moritz, B., Eder, J., Meister, B., & Heitger, A. (2001) · Medical and Pediatric Oncology · doi:10.1002/1096-911x(20010201)36:2 · Cited by 12 · see citing works

Childhood Leukemias

(2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511977633 · Cited by 12 · see citing works

Ewing’s sarcoma as second malignancy following a short latency in unilateral retinoblastoma

Tahasildar, N. S., Goni, V., Bhagwat, K., Tripathy, S. K., & Panda, B. B. (2011) · Journal of Orthopaedics and Traumatology · doi:10.1007/s10195-011-0152-0 · Cited by 10 · see citing works

Pan-cancer analysis of whole genomes

The ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium, Aaltonen, L. A., Abascal, F., Abeshouse, A., Aburatani, H., Adams, D. J., Agrawal, N., Ahn, K. S., Ahn, S.-M., Aikata, H., et al. (2020) · Nature · doi:10.1038/s41586-020-1969-6 · Cited by 3,064 · see citing works

Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer

Pritchard, C. C., Mateo, J., Walsh, M. F., De Sarkar, N., Abida, W., Beltran, H., Garofalo, A., Gulati, R., Carreira, S., Eeles, R., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603144 · Cited by 1,680 · see citing works

The landscape of genomic alterations across childhood cancers

ICGC PedBrain-Seq Project, Gröbner, S. N., ICGC MMML-Seq Project, Worst, B. C., Weischenfeldt, J., Buchhalter, I., Kleinheinz, K., Rudneva, V. A., Johann, P. D., Balasubramanian, G. P., et al. (2018) · Nature · doi:10.1038/nature25480 · Cited by 1,572 · see citing works

The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia

Liu, Y., Easton, J., Shao, Y., Maciaszek, J., Wang, Z., Wilkinson, M. R., McCastlain, K., Edmonson, M., Pounds, S. B., Shi, L., et al. (2017) · Nature Genetics · doi:10.1038/ng.3909 · Cited by 918 · see citing works

Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours

Ma, X., Liu, Y., Liu, Y., Alexandrov, L. B., Edmonson, M. N., Gawad, C., Zhou, X., Li, Y., Rusch, M. C., Easton, J., et al. (2018) · Nature · doi:10.1038/nature25795 · Cited by 901 · see citing works

Immune checkpoint inhibition for hypermutant glioblastoma multiforme resulting from germline biallelic mismatch repair deficiency

Bouffet, E., Larouche, V., Campbell, B. B., Merico, D., de Borja, R., Aronson, M., Durno, C., Krueger, J., Cabric, V., Ramaswamy, V., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.66.6552 · Cited by 857 · see citing works

Ewing sarcoma

Grünewald, T. G. P., Cidre-Aranaz, F., Surdez, D., Tomazou, E. M., de Álava, E., Kovar, H., Sorensen, P. H., Delattre, O., & Dirksen, U. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0003-x · Cited by 873 · see citing works

The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions

Bolouri, H., Farrar, J. E., Triche, T. J., Ries, R. E., Lim, E. L., Alonzo, T. A., Ma, Y. P., Moore, R. A., Mungall, A. J. J., Marra, M. A., et al. (2017) · Nature Medicine · doi:10.1038/nm.4439 · Cited by 844 · see citing works

Pathogenic Germline Variants in 10,389 Adult Cancers

Huang, K., Mashl, R. J., Wu, Y., Ritter, D., Wang, J., Oh, C., Paczkowska, M., Reynolds, S. M., Wyczalkowski, M. A., Oak, N., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.039 · Cited by 838 · see citing works

Diagnostic Utility of Exome Sequencing for Kidney Disease

Groopman, E., Marasà, M., Cameron‐Christie, S., Petrovski, S., Aggarwal, V. S., Rasouly, H. M., Li, Y., Zhang, J., Nestor, J. G., Krithivasan, P., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1806891 · Cited by 788 · see citing works

Comprehensive Analysis of Hypermutation in Human Cancer

Campbell, B. B., Light, N. D., Fabrizio, D. A., Zatzman, M., Fuligni, F., de Borja, R., Davidson, S., Edwards, M., Elvin, J. A., Hodel, K. P., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.048 · Cited by 759 · see citing works

Osteosarcoma

Beird, H. C., Bielack, S. S., Flanagan, A. M., Gill, J., Heymann, D., Janeway, K. A., Livingston, J. A., Roberts, R. D., Strauss, S. J., & Gorlick, R. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00409-y · Cited by 660 · see citing works

The emerging clinical relevance of genomics in cancer medicine

Berger, M. F., & Mardis, E. R. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0002-6 · Cited by 627 · see citing works

Advancements in Next-Generation Sequencing

Levy, S., & Myers, R. (2016) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-083115-022413 · Cited by 598 · see citing works

Clinical Cancer Advances 2017: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

Burstein, H. J., Krilov, L., Aragon‐Ching, J. B., Baxter, N. N., Chiorean, E. G., Chow, W. A., Groot, J. F. D., Devine, S. M., DuBois, S. G., El‐Deiry, W. S., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.71.5292 · Cited by 601 · see citing works

Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome

Kratz, C. P., Achatz, M. I., Brugières, L., Frebourg, T., Garber, J. E., Greer, M.-L. C., Hansford, J. R., Janeway, K. A., Kohlmann, W. K., McGee, R., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0408 · Cited by 534 · see citing works

Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing

Mandelker, D. L., Zhang, L., Kemel, Y. M., Stadler, Z. K., Vijai, J., Zehir, A., Pradhan, N., Arnold, A. G., Walsh, M. F., Li, Y., et al. (2017) · JAMA · doi:10.1001/jama.2017.11137 · Cited by 513 · see citing works

Implementing Genome-Driven Oncology

Hyman, D. M., Taylor, B. S., & Baselga, J. M. (2017) · Cell · doi:10.1016/j.cell.2016.12.015 · Cited by 505 · see citing works

Germline and somatic genetics of osteosarcoma — connecting aetiology, biology and therapy

Gianferante, D. M., Mirabello, L. J., & Savage, S. A. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.16 · Cited by 470 · see citing works

New insights into the generation and role of de novo mutations in health and disease

Acuña‐Hidalgo, R., Veltman, J. A., & Hoischen, A. (2016) · Genome biology · doi:10.1186/s13059-016-1110-1 · Cited by 451 · see citing works

Estimating the total incidence of global childhood cancer: a simulation-based analysis

Ward, Z. J., Yeh, J. M., Bhakta, N. H., Frazier, A. L., & Atun, R. A. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30909-4 · Cited by 438 · see citing works

Therapy-related myeloid neoplasms: when genetics and environment collide

McNerney, M. E., Godley, L. A., & Beau, M. M. L. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.60 · Cited by 422 · see citing works

The global burden of childhood and adolescent cancer in 2017: an analysis of the Global Burden of Disease Study 2017

Force, L. M., Abdollahpour, I., Advani, S. M., Agius, D., Ahmadian, E., Alahdab, F., Alam, S., Alebel, A., Alipour, V., Allen, C. A., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30339-0 · Cited by 403 · see citing works

Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort

Waszak, S. M., Northcott, P. A., Buchhalter, I., Robinson, G. W., Sutter, C., Gröbner, S. N., Grund, K., Brugières, L., Jones, D., Pajtler, K. W., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30242-0 · Cited by 397 · see citing works

Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer

Wong, M., Mayoh, C., Lau, L. M. S., Khuong-Quang, D.-A., Pinese, M., Kumar, A., Barahona, P., Wilkie, E. E., Sullivan, P. A., Bowen-James, R., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1072-4 · Cited by 397 · see citing works

Exploring genomic alteration in pediatric cancer using ProteinPaint

Zhou, X., Edmonson, M. N., Wilkinson, M. R., Patel, A., Wu, G., Liu, Y., Li, Y., Zhang, Z., Rusch, M., Parker, M. D., et al. (2015) · Nature Genetics · doi:10.1038/ng.3466 · Cited by 395 · see citing works

Review of Osteosarcoma and Current Management

Durfee, R. A., Mohammed, M., & Luu, H. H. (2016) · Rheumatology and Therapy · doi:10.1007/s40744-016-0046-y · Cited by 397 · see citing works

Fanconi anaemia and cancer: an intricate relationship

Nalepa, G., & Clapp, D. W. (2018) · Nature reviews. Cancer · doi:10.1038/nrc.2017.116 · Cited by 388 · see citing works

The Significance of Mitochondrial Dysfunction in Cancer

Luo, Y., Ma, J., & Lu, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165598 · Cited by 367 · see citing works

Next-generation personalised medicine for high-risk paediatric cancer patients – The INFORM pilot study

Worst, B. C., van Tilburg, C. M., Balasubramanian, G. P., Fiesel, P., Witt, R., Freitag, A., Boudalil, M., Previti, C., Wolf, S., Schmidt, S., et al. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.06.009 · Cited by 329 · see citing works

Analysis of error profiles in deep next-generation sequencing data

Ma, X., Shao, Y., Tian, L., Flasch, D. A., Mulder, H. L., Edmonson, M. N., Liu, Y., Chen, X. '., Newman, S., Nakitandwe, J., et al. (2019) · Genome biology · doi:10.1186/s13059-019-1659-6 · Cited by 318 · see citing works

Pediatric Brain Tumors

Udaka, Y. T., & Packer, R. J. (2018) · Neurologic Clinics · doi:10.1016/j.ncl.2018.04.009 · Cited by 289 · see citing works

Comparative review of human and canine osteosarcoma: morphology, epidemiology, prognosis, treatment and genetics

Simpson, S., Dunning, M., de Brot, S., Grau‐Roma, L., Mongan, N. P., & Rutland, C. S. (2017) · Acta veterinaria Scandinavica · doi:10.1186/s13028-017-0341-9 · Cited by 294 · see citing works

Pediatric Exposures to Ionizing Radiation: Carcinogenic Considerations

Kutanzi, K. R., Lumen, A., Koturbash, I., & Miousse, I. R. (2016) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph13111057 · Cited by 287 · see citing works

Childhood cancer predisposition syndromes—A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology

Ripperger, T., Bielack, S., Borkhardt, A., Brecht, I. B., Burkhardt, B., Calaminus, G., Debatin, K., Deubzer, H. E., Dirksen, U., Eckert, C., et al. (2017) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38142 · Cited by 280 · see citing works

St. Jude Cloud: A Pediatric Cancer Genomic Data-Sharing Ecosystem

McLeod, C., Gout, A. M., Zhou, X., Thrasher, A., Rahbarinia, D., Brady, S. W., Macias, M., Birch, K., Finkelstein, D., Sunny, J., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1230 · Cited by 262 · see citing works

Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma

Mirabello, L., Zhu, B., Koster, R., Karlins, E., Dean, M., Yeager, M., Gianferante, M., Spector, L. G., Morton, L. M., Karyadi, D., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.0197 · Cited by 243 · see citing works

Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy

Kline, C., Joseph, N. M., Grenert, J. P., Ziffle, J. V., Talevich, E., Onodera, C. S., Aboian, M., Cha, S., Raleigh, D. R., Braunstein, S. E., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now254 · Cited by 228 · see citing works

Clinical cancer genomic profiling

Chakravarty, D., & Solit, D. B. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-021-00338-8 · Cited by 227 · see citing works

Retinoblastoma and Neuroblastoma Predisposition and Surveillance

Kamihara, J., Bourdeaut, F., Foulkes, W. D., Molenaar, J. J., Mossé, Y. P., Nakagawara, A., Parareda, A., Scollon, S., Schneider, K. W., Skalet, A. H., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0652 · Cited by 228 · see citing works

The genomic landscape of pediatric cancers: Implications for diagnosis and treatment

Sweet-Cordero, A., & Biegel, J. A. (2019) · Science · doi:10.1126/science.aaw3535 · Cited by 226 · see citing works

Genomes for Kids: The Scope of Pathogenic Mutations in Pediatric Cancer Revealed by Comprehensive DNA and RNA Sequencing

Newman, S., Nakitandwe, J., Kesserwan, C. A., Azzato, E. M., Wheeler, D. A., Rusch, M., Shurtleff, S. A., Hedges, D. J., Hamilton, K. V., Foy, S. G., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1631 · Cited by 219 · see citing works

A Summary of the Inaugural WHO Classification of Pediatric Tumors: Transitioning from the Optical into the Molecular Era

Pfister, S. M., Reyes‐Múgica, M., Chan, J. K. C., Hasle, H., Lazar, A. J., Rossi, S., Ferrari, A., Jarzembowski, J. A., Pritchard‐Jones, K., Hill, D. A., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1094 · Cited by 216 · see citing works

An integrated tumor, immune and microbiome atlas of colon cancer

Roelands, J. P., Kuppen, P. J. K., Ahmed, E. I., Mall, R., Masoodi, T., Singh, P., Monaco, G., Raynaud, C. M., de Miranda, N. F. C. C., Ferraro, L., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02324-5 · Cited by 217 · see citing works

Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome

Rusch, M., Nakitandwe, J., Shurtleff, S. A., Newman, S., Zhang, Z., Edmonson, M. N., Parker, M. D., Jiao, Y., Ma, X., Liu, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06485-7 · Cited by 212 · see citing works

Monogenic and polygenic determinants of sarcoma risk: an international genetic study

Ballinger, M. L., Goode, D. L., Ray-Coquard, I. L., James, P. A., Mitchell, G., Niedermayr, E., Puri, A., Schiffman, J. D., Dite, G. S., Cipponi, A., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30147-4 · Cited by 214 · see citing works

The genomic landscape of pediatric myelodysplastic syndromes

Schwartz, J. R., Ma, J., Westover, T., Walsh, M. P., Wang, S., Bryant, V. L., Song, G., Wu, G., Easton, J. B., Kesserwan, C. A., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01590-5 · Cited by 209 · see citing works

Future cancer research priorities in the USA: a Lancet Oncology Commission

Jaffee, E. M., Dang, C. V., Agus, D. B., Alexander, B. M., Anderson, K. C., Ashworth, A., Barker, A. D., Bastani, R., Bhatia, S. N., Bluestone, J. A., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30698-8 · Cited by 211 · see citing works

Nrf2 targeting by sulforaphane: A potential therapy for cancer treatment

Russo, M., Spagnuolo, C., Russo, G. L., Skalicka‐Woźniak, K., Daglia, M., Sobarzo‐Sánchez, E., Nabavi, S. F., & Nabavi, S. M. (2016) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2016.1259983 · Cited by 199 · see citing works

Pediatric Cancer Predisposition and Surveillance: An Overview, and a Tribute to Alfred G. Knudson Jr

Brodeur, G. M., Nichols, K. E., Plon, S. E., Schiffman, J. D., & Malkin, D. M. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0702 · Cited by 193 · see citing works

Implementation of next generation sequencing into pediatric hematology-oncology practice: moving beyond actionable alterations

Oberg, J. A., Bender, J. G., Sulis, M. L., Pendrick, D., Sireci, A. N., Hsiao, S. J., Turk, A. T., Cruz, F. S. D., Hibshoosh, H. H., Remotti, H. E., et al. (2016) · Genome Medicine · doi:10.1186/s13073-016-0389-6 · Cited by 184 · see citing works

Acute lymphoblastic leukaemia

Pagliaro, L., Chen, S., Herranz, D., Mecucci, C., Harrison, C. J., Mullighan, C. G., Zhang, M., Zhu, C. H., Boissel, N., Winter, S. S., et al. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00525-x · Cited by 197 · see citing works

How I diagnose and manage individuals at risk for inherited myeloid malignancies

The University of Chicago Hematopoietic Malignancies Cancer Risk Team (2016) · Blood · doi:10.1182/blood-2016-05-670240 · Cited by 181 · see citing works

Somatic and germline genomics in paediatric acute lymphoblastic leukaemia

Pui, C., Nichols, K. E., & Yang, J. J. J. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0136-6 · Cited by 180 · see citing works

TP53 Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children

Qian, M., Cao, X., Devidas, M., Yang, W., Cheng, C., Dai, Y. E., Carroll, A. J., Heerema, N. A., Zhang, H., Moriyama, T., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.75.5215 · Cited by 175 · see citing works

The European MAPPYACTS Trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent Malignancies

Berlanga, P., Pierron, G., Lacroix, L., Chicard, M., de Beaumais, T. A., Marchais, A., Harttrampf, A. C., Iddir, Y., Larive, A., Soriano, A., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1136 · Cited by 174 · see citing works

Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors

Fiala, E. M., Jayakumaran, G., Mauguen, A., Kennedy, J. A., Bouvier, N., Kemel, Y. M., Fleischut, M. H., Maio, A., Salo‐Mullen, E. E., Sheehan, M. R., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00172-1 · Cited by 172 · see citing works

Germline Elongator mutations in Sonic Hedgehog medulloblastoma

Waszak, S. M., Robinson, G. W., Gudenas, B. L., Smith, K. S., Forget, A., Kojic, M., García-López, J., Hadley, J. L., Hamilton, K. V., Indersie, É., et al. (2020) · Nature · doi:10.1038/s41586-020-2164-5 · Cited by 164 · see citing works

Fumarate hydratase in cancer: A multifaceted tumour suppressor

Schmidt, C., Sciacovelli, M., & Frezza, C. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.002 · Cited by 163 · see citing works

AI applications in robotics, diagnostic image analysis and precision medicine: Current limitations, future trends, guidelines on CAD systems for medicine

Habuza, T., Navaz, A. N., Hashim, F., Alnajjar, F., Zaki, N., Serhani, M. A., & Statsenko, Y. A. (2021) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2021.100596 · Cited by 173 · see citing works

Risk, Risk Factors, and Surveillance of Subsequent Malignant Neoplasms in Survivors of Childhood Cancer: A Review

Turcotte, L. M., Neglia, J. P., Reulen, R. C., Ronckers, C. M., van Leeuwen, F. E., Morton, L. M., Hodgson, D. C., Yasui, Y., Oeffinger, K. C., & Henderson, T. O. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.7764 · Cited by 161 · see citing works

Molecular characteristics and therapeutic vulnerabilities across paediatric solid tumours

Jones, D., Banito, A., Grünewald, T. G. P., Haber, M., Jäger, N., Kool, M., Milde, T., Molenaar, J. J., Nabbi, A., Pugh, T. J., et al. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0169-x · Cited by 155 · see citing works

Genetic features of myelodysplastic syndrome and aplastic anemia in pediatric and young adult patients

Keel, S., Scott, A., Sánchez-Bonilla, M., Ho, P. A., Gülsüner, S., Pritchard, C. C., Abkowitz, J. L., King, M., Walsh, T., & Shimamura, A. (2016) · Haematologica · doi:10.3324/haematol.2016.149476 · Cited by 157 · see citing works

Association Between Birth Defects and Cancer Risk Among Children and Adolescents in a Population-Based Assessment of 10 Million Live Births

Lupo, P. J., Schraw, J. M., Desrosiers, T. A., Nembhard, W. N., Langlois, P. H., Canfield, M. A., Copeland, G. E., Meyer, R. E., Brown, A. L., Chambers, T. M., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.1215 · Cited by 158 · see citing works

Transforming Cancer Prevention through Precision Medicine and Immune-oncology

Kensler, T. W., Spira, A. E., Garber, J. E., Szabo, E. M., Lee, J. J., Dong, Z., Dannenberg, A. J., Hait, W. N., Blackburn, E. H., Davidson, N. E., et al. (2016) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-15-0406 · Cited by 153 · see citing works

Advances in germline predisposition to acute leukaemias and myeloid neoplasms

Klco, J. M., & Mullighan, C. G. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-00315-z · Cited by 159 · see citing works

Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia

Gocho, Y., Liu, J., Hu, J., Yang, W., Dharia, N. V., Zhang, J., Shi, H., Du, G., John, A. J., Lin, T.-N., et al. (2021) · Nature Cancer · doi:10.1038/s43018-020-00167-4 · Cited by 153 · see citing works

Therapeutic Implications of Germline Testing in Patients With Advanced Cancers

Stadler, Z. K., Maio, A., Chakravarty, D., Kemel, Y. M., Sheehan, M. R., Salo‐Mullen, E. E., Tkachuk, K. A., Fong, C. J., Nguyen, B., Erakky, A., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.03661 · Cited by 153 · see citing works

Estimating the selective effects of heterozygous protein-truncating variants from human exome data

Cassa, C. A., Weghorn, D., Balick, D. J., Jordan, D. M., Nusinow, D. P., Samocha, K. E., O’Donnell‐Luria, A., MacArthur, D. G., Daly, M. J., Beier, D. R., et al. (2017) · Nature Genetics · doi:10.1038/ng.3831 · Cited by 151 · see citing works

Mutational Landscape and Patterns of Clonal Evolution in Relapsed Pediatric Acute Lymphoblastic Leukemia

Waanders, E., Gu, Z., Dobson, S. M., Antić, Ž., Crawford, J. C., Ma, X., Edmonson, M. N., Payne-Turner, D., van de Vorst, M., Jongmans, M. C. J., et al. (2020) · Blood Cancer Discovery · doi:10.1158/0008-5472.bcd-19-0041 · Cited by 145 · see citing works

Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children’s Oncology Group

Shulman, D. S., Klega, K., Imamovic-Tuco, A., Clapp, A., Nag, A., Thorner, A. R., Van Allen, E., Ha, G., Lessnick, S. L., Gorlick, R., et al. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0212-9 · Cited by 149 · see citing works

Management of ALL in adults: 2024 ELN recommendations from a European expert panel

Gökbuget, N., Boissel, N., Chiaretti, S., Dombret, H., Doubek, M., Fielding, A. K., Foà, R., Giebel, S., Hoelzer, D. F., Hunault, M., et al. (2024) · Blood · doi:10.1182/blood.2023023568 · Cited by 151 · see citing works

Molecular Screening for Cancer Treatment Optimization (MOSCATO-01) in Pediatric Patients: A Single-Institutional Prospective Molecular Stratification Trial

Harttrampf, A. C., Lacroix, L., Deloger, M., Deschamps, F., Puget, S., Auger, N., Vielh, P. R., Varlet, P., Balogh, Z., Abbou, S. D., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0381 · Cited by 146 · see citing works

Genetic Counselor Recommendations for Cancer Predisposition Evaluation and Surveillance in the Pediatric Oncology Patient

Druker, H. A., Zelley, K., McGee, R. B., Scollon, S., Kohlmann, W. K., Schneider, K. A., & Schneider, K. W. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0834 · Cited by 143 · see citing works

Genetic Risk for Subsequent Neoplasms Among Long-Term Survivors of Childhood Cancer

Wang, Z., Wilson, C. L., Easton, J. B., Thrasher, A., Mulder, H. L., Liu, Q., Hedges, D. J., Wang, S., Rusch, M., Edmonson, M. N., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.77.8589 · Cited by 140 · see citing works

Rhabdomyosarcoma, Ewing Sarcoma, and Other Round Cell Sarcomas

Pappo, A. S., & Dirksen, U. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.7402 · Cited by 138 · see citing works

Precision oncology in the age of integrative genomics

Kumar‐Sinha, C., & Chinnaiyan, A. M. (2018) · Nature Biotechnology · doi:10.1038/nbt.4017 · Cited by 137 · see citing works

Enrichment of Targetable Mutations in the Relapsed Neuroblastoma Genome

Padovan-Merhar, O. M., Raman, P., Ostrovnaya, I., Kalletla, K., Rubnitz, K. R., Sanford, E. M., Ali, S. M., Miller, V. A., Mossé, Y. P., Granger, M. P., et al. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006501 · Cited by 134 · see citing works

Next-Generation Sequencing StrategiesPreprint

Levy, S., & Boone, B. E. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025791 · Cited by 133 · see citing works

Predisposition to cancer in children and adolescents

Kratz, C. P., Jongmans, M. C., Cavé, H., Wimmer, K., Behjati, S., Guerrini-Rousseau, L., Milde, T., Pajtler, K. W., Golmard, L., Gauthier-Villars, M., et al. (2021) · The Lancet Child &amp; Adolescent Health · doi:10.1016/s2352-4642(20)30275-3 · Cited by 129 · see citing works

Canine osteosarcoma genome sequencing identifies recurrent mutations in DMD and the histone methyltransferase gene SETD2

Gardner, H. L., Sivaprakasam, K., Briones, N., Zismann, V., Perdigones, N., Drenner, K., Facista, S., Richholt, R., Liang, W., Aldrich, J., et al. (2019) · Communications Biology · doi:10.1038/s42003-019-0487-2 · Cited by 120 · see citing works

Precancer Atlas to Drive Precision Prevention Trials

Spira, A. E., Yurgelun, M. B., Alexandrov, L. B., Rao, A., Bejar, R., Polyák, K., Giannakis, M., Shilatifard, A., Finn, O. J., Dhodapkar, M., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2346 · Cited by 130 · see citing works

Cancer Screening Recommendations and Clinical Management of Inherited Gastrointestinal Cancer Syndromes in Childhood

Achatz, M. I., Porter, C. C., Brugières, L., Druker, H. A., Frébourg, T., Foulkes, W. D., Kratz, C. P., Kuiper, R. P., Hansford, J. R., Salvador, H., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0790 · Cited by 129 · see citing works

Clinical utility of custom-designed NGS panel testing in pediatric tumors

Surrey, L. F., MacFarland, S. P., Chang, F., Cao, K., Rathi, K. S., Akgumus, G. T., Gallo, D., Lin, F., Gleason, A. G., Raman, P., et al. (2019) · Genome Medicine · doi:10.1186/s13073-019-0644-8 · Cited by 129 · see citing works

Rare pathogenic variants predispose to hepatocellular carcinoma in nonalcoholic fatty liver disease

Pelusi, S., Baselli, G., Pietrelli, A., Dongiovanni, P., Donati, B., McCain, M. V., Meroni, M., Fracanzani, A. L., Romagnoli, R., Petta, S., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-39998-2 · Cited by 125 · see citing works

Global efforts toward the cure of childhood acute lymphoblastic leukaemia

Pui, C., Yang, J. J. J., Bhakta, N. H., & Galindo, C. R. (2018) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(18)30066-x · Cited by 129 · see citing works

The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutations

Villani, A., Davidson, S., Kanwar, N., Lo, W. W., Li, Y., Cohen‐Gogo, S., Fuligni, F., Edward, L.-M., Light, N. D., Layeghifard, M., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00474-y · Cited by 121 · see citing works

Li‐Fraumeni syndrome: a paradigm for the understanding of hereditary cancer predisposition

Valdez, J. M., Nichols, K. E., & Kesserwan, C. A. (2016) · British Journal of Haematology · doi:10.1111/bjh.14461 · Cited by 121 · see citing works

Contribution of de novo and mosaic TP53 mutations to Li-Fraumeni syndrome

Renaux‐Petel, M., Charbonnier, F., Théry, J., Fermey, P., Lienard, G., Bou, J., Coutant, S., Vézain, M., Kasper, E., Fourneaux, S., et al. (2017) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2017-104976 · Cited by 120 · see citing works

Nationwide germline whole genome sequencing of 198 consecutive pediatric cancer patients reveals a high incidence of cancer prone syndromes

Byrjalsen, A., Hansen, T. V. O., Stoltze, U. K., Mehrjouy, M. M., Barnkob, N. M., Hjalgrim, L. L., Mathiasen, R., Lautrup, C. K., Gregersen, P. A., Hasle, H., et al. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1009231 · Cited by 119 · see citing works

MultiDimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A Report from the Center for Cancer Research

Chang, W., Brohl, A. S., Patidar, R., Sindiri, S., Shern, J. F., Wei, J. S., Song, Y., Yohe, M. E., Gryder, B. E., Zhang, S., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2717 · Cited by 118 · see citing works

Childhood Cancer: Occurrence, Treatment and Risk of Second Primary Malignancies

Zahnreich, S., & Schmidberger, H. (2021) · Cancers · doi:10.3390/cancers13112607 · Cited by 118 · see citing works

Recommendations for Childhood Cancer Screening and Surveillance in DNA Repair Disorders

Walsh, M. F., Chang, V. Y., Kohlmann, W. K., Scott, H. S., Cunniff, C. M., Bourdeaut, F., Molenaar, J. J., Porter, C. C., Sandlund, J. T., Plon, S. E., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0465 · Cited by 119 · see citing works

Fumarate hydratase (FH) and cancer: a paradigm of oncometabolism

Valcárcel-Jiménez, L., & Frezza, C. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02412-w · Cited by 115 · see citing works

Inherited DNA-Repair Defects in Colorectal Cancer

AlDubayan, S. H., Giannakis, M., Moore, N. D., Han, G. C., Reardon, B. M., Hamada, T., Mu, X. J., Nishihara, R., Qian, Z., Liu, L., et al. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.01.018 · Cited by 114 · see citing works

Germline Cancer Predisposition Variants in Pediatric Rhabdomyosarcoma: A Report From the Children’s Oncology Group

Li, H., Sisoudiya, S. D., Martin‐Giacalone, B. A., Khayat, M. M., Dugan‐Perez, S., Marquez-Do, D. A., Scheurer, M. E., Muzny, D. M., Boerwinkle, E., Gibbs, R. A., et al. (2020) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaa204 · Cited by 111 · see citing works

The Impact of Next-Generation Sequencing on Cancer Genomics: From Discovery to ClinicPreprint

Mardis, E. R. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a036269 · Cited by 114 · see citing works

GWAS in childhood acute lymphoblastic leukemia reveals novel genetic associations at chromosomes 17q12 and 8q24.21

Wiemels, J. L., Walsh, K. M., de Smith, A. J., Metayer, C., Gonseth, S., Hansen, H. M., Francis, S. S., Ojha, J., Smirnov, I. V., Barcellos, L. F., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02596-9 · Cited by 106 · see citing works

Germline Genetic Predisposition to Hematologic Malignancy

Furutani, E., & Shimamura, A. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.8644 · Cited by 105 · see citing works

The context-specific role of germline pathogenicity in tumorigenesis

Srinivasan, P., Bandlamudi, C., Jonsson, P., Kemel, Y. M., Chavan, S. S., Richards, A. L., Penson, A. V., Bielski, C. M., Fong, C. J., Syed, A., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00949-1 · Cited by 107 · see citing works

Presented Abstracts from the Thirty Fourth Annual Education Conference of the National Society of Genetic Counselors (Pittsburgh, PA, October 2015)

Yashar, B. M., Edelman, E. A., Darin, K., & McClelland, Z. (2015) · Journal of Genetic Counseling · doi:10.1007/s10897-015-9893-x · Cited by 1 · see citing works

Heritable Mutations in Pediatric Cancer

(2016) · AAP Grand Rounds · doi:10.1542/gr.35-4-43

High Yield of Pathogenic Germline Mutations Causative or Likely Causative of the Cancer Phenotype in Selected Children with Cancer

Diets, I., Waanders, E., Ligtenberg, M., van Bladel, D. V., Kamping, E., Hoogerbrugge, P., Hopman, S., Olderode-Berends, M., Gerkes, E., Koolen, D., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1725 · Cited by 59 · see citing works

Incidence of Germline Mutations in Cancer-Predisposition Genes in Children with Hematologic Malignancies: a Report from the Pediatric Cancer Genome Project

Walsh, M. P., Wu, G., Edmonson, M. N., Gruber, T. A., Easton, J. B., Yergeau, D. A., Vadodaria, B., Ma, X., Chen, X. '., McGee, R. B., et al. (2014) · Blood · doi:10.1182/blood.v124.21.127.127 · Cited by 12 · see citing works

Genes underpinning predisposition to childhood cancer

Sylvester, D. E. (2020) · The Sydney eScholarship Repository (The University of Sydney)